Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Feb 28, 2025 | (FY)Feb 29, 2024 | (FY)Feb 28, 2023 | (FY)Feb 28, 2022 | (FY)Feb 28, 2021 | (FY)Feb 29, 2020 | |
|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||
| Cash from operating activities | 50.76%2.6B | -55.28%1.73B | 316.48%3.86B | -203.33%-1.78B | -23.13%1.73B | 2.25B |
| Net profit before non-cash adjustment | 24.40%2.06B | 32.18%1.66B | -92.86%1.25B | 1,722.47%17.56B | -41.55%963.76M | --1.65B |
| Total adjustment of non-cash items | 94.75%542.15M | -39.15%278.38M | 102.84%457.48M | -1,921.84%-16.09B | 107.96%883.33M | --424.77M |
| -Depreciation and amortization | 0.92%160.59M | 1.55%159.12M | -62.18%156.68M | -15.44%414.28M | 0.36%489.91M | --488.17M |
| -Disposal profit | ---23.13M | --0 | ---- | -10,820.21%-16.58B | --154.7M | ---- |
| -Other non-cash items | 239.34%404.69M | -60.35%119.26M | 291.81%300.8M | -67.84%76.77M | 476.50%238.72M | ---63.41M |
| Changes in working capital | 99.06%-1.98M | -109.78%-210.06M | 166.02%2.15B | -2,589.49%-3.25B | -170.42%-121.02M | --171.87M |
| -Change in receivables | 172.27%441.17M | -2,785.42%-610.47M | -802.60%-21.16M | -102.47%-2.34M | 293.22%95.06M | ---49.2M |
| -Change in inventory | -294.03%-334.43M | -103.89%-84.87M | 159.82%2.18B | -1,198.18%-3.64B | 254.75%331.87M | --93.55M |
| -Change in payables | -201.37%-159.48M | 285.37%157.31M | -131.56%-84.87M | 632.86%268.94M | -5.75%-50.47M | ---47.73M |
| -Provision for loans, leases and other losses | 42.78%124.63M | 131.12%87.28M | 680.46%37.77M | 97.33%-6.51M | -8,443.29%-243.91M | ---2.86M |
| -Changes in other current assets | -130.69%-73.87M | 554.34%240.69M | -71.60%36.78M | 151.08%129.52M | -242.38%-253.57M | --178.09M |
| Dividends paid (cash flow from operating activities) | ||||||
| Dividends received (cash flow from operating activities) | ||||||
| Interest paid (cash flow from operating activities) | 61.98%-806K | -145.65%-2.12M | 95.77%-863K | 4.21%-20.38M | 34.54%-21.28M | -32.51M |
| Interest received (cash flow from operating activities) | 76.61%3.56M | 65.00%2.02M | -84.35%1.22M | -49.36%7.81M | -27.28%15.43M | 21.22M |
| Tax refund paid | -142.00%-1.1B | 132.55%2.62B | -265.93%-8.04B | -482.17%-2.2B | 49.57%-377.3M | -748.15M |
| Other operating cash inflow (outflow) | 18.65M | 0 | 97.49%-4.73M | -18,838,400.00%-188.39M | -1K | 0 |
| Operating cash flow | -64.86%1.53B | 203.87%4.34B | -0.00%-4.18B | -411.33%-4.18B | -9.63%1.34B | --1.49B |
| Investing cash flow | ||||||
| Net PPE purchase and sale | 71.53%-55.07M | -1.19%-193.45M | -145.33%-191.17M | -227.43%-77.93M | 96.24%-23.8M | ---633.15M |
| Net intangibles purchase and sale | 39.51%-75.58M | -91.34%-124.95M | -282.71%-65.3M | 35.95%-17.06M | 63.06%-26.64M | ---72.11M |
| Net business purchase and sale | ---- | ---- | ---- | --17.35B | ---- | ---- |
| Net investment product transactions | --44.25M | --0 | ---- | ---- | ---- | ---- |
| Net changes in other investments | 42.96%-13.5M | -334.83%-23.67M | 91.47%-5.44M | -68.67%-63.82M | -315.14%-37.84M | ---9.11M |
| Investing cash flow | 70.79%-99.9M | -30.60%-342.07M | -101.52%-261.92M | 19,571.46%17.19B | 87.64%-88.27M | ---714.38M |
| Financing cash flow | ||||||
| Net issuance payments of debt | ---200M | --0 | -790.91%-980M | 45.00%-110M | -290.48%-200M | --105M |
| Net common stock issuance | 78.01%-44.89M | -148.87%-204.11M | 660.72%417.63M | -296.11%-74.48M | -284.99%-18.8M | ---4.88M |
| Increase or decrease of lease financing | ---- | ---- | ---- | 25.46%-201.91M | 1.71%-270.88M | ---275.6M |
| Cash dividends paid | -30.68%-362.45M | -7.37%-277.36M | 0.94%-258.32M | 11.32%-260.76M | 0.06%-294.05M | ---294.23M |
| Net other fund-raising expenses | 198,000.00%1.98M | -200.00%-1K | --1K | ---- | ---- | ---- |
| Financing cash flow | -25.73%-605.36M | 41.33%-481.47M | -26.81%-820.69M | 17.43%-647.16M | -66.85%-783.73M | ---469.71M |
| Net cash flow | ||||||
| Beginning cash position | 24.75%17.74B | -27.01%14.22B | 174.83%19.49B | 7.09%7.09B | 4.37%6.62B | --6.34B |
| Current changes in cash | -76.68%820.71M | 166.86%3.52B | -142.59%-5.26B | 2,524.71%12.36B | 56.00%470.91M | --301.88M |
| Effect of exchange rate changes | ---- | ---- | ---- | 3,026.95%35.3M | 95.11%-1.21M | ---24.68M |
| Cash adjustments other than cash changes | 0.00%-1K | ---1K | ---- | 150.00%1K | -100.00%-2K | ---1K |
| End cash Position | 4.63%18.56B | 24.75%17.74B | -27.01%14.22B | 174.83%19.49B | 7.09%7.09B | --6.62B |
| Free cash flow | -65.33%1.4B | 190.69%4.02B | -3.78%-4.44B | -430.83%-4.28B | 65.55%1.29B | --780.71M |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |